Visikol

company

About

Visikol is a contract research organization focused on digital pathology, 3D tissue imaging and 3D cell culture assays and models.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$55K
Industries
Analytics,Biotechnology,Developer Tools,Information Technology,Neuroscience
Founded date
Feb 22, 2016
Number Of Employee
11 - 50
Operating Status
Active

Visikol is a CRO focused on advanced drug discovery that is leading the field of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$2.65M
Visikol has raised a total of $2.65M in funding over 2 rounds. Their latest funding was raised on Apr 26, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 26, 2021 Grant $1.63M 1 Detail
Apr 17, 2019 Grant $0.97M 1 National Science Foundation Detail
Feb 1, 2019 Grant $55K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Visikol is funded by 2 investors. National Science Foundation and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
National Institutes of Health Grant